September 29th 2023
Benefits of exogenous hormone use, as well as data indicating no association with increased breast cancer risk, were discussed at The Menopause Society 2023 Annual Meeting.
23rd Annual International Congress on the Future of Breast Cancer® East
Register Now!
Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
5th Annual Precision Medicine Symposium: An Illustrated Tumor Board
Register Now!
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
Register Now!
Expanding Options Beyond Conventional Therapy in HR+ Breast Cancer to Overcome Unmet Needs
View More
21st Annual School of Breast Oncology
Register Now!
41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®
Register Now!
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers
View More
Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care
View More
Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers
View More
Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens
View More
Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer
View More
Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care
View More
Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow
View More
BURST CME™: Addressing Current Standards and Unmet Needs in Patients with Metastatic Breast Cancer
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio
View More
Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care
View More
Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
View More
Community Practice Connections™: Clinical Decision Making Under New Paradigms for HR+/HER2-Breast Cancer
View More
School of Breast Oncology
View More
41st Annual Miami Breast Cancer Conference®
Register Now!
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
Optimizing Pain Management for Breast Cancer Surgery Patients in the Age of the Opioid Epidemic
View More
Identifying and Mitigating Disparities in Breast Cancer Care: Improving Diagnostics, Trial Access and Care for All Patients
View More
Medical Crossfire®: Optimizing Treatment Sequencing for HR+/HER2- Metastatic Breast Cancer Based on Emerging Evidence and Evolving Algorithms
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
Community Practice Connections™: What’s Next for Patients with Breast Cancer, and How Can We Effectively Optimize PARP-, HER2/3-, and TROP2-Targeted Regimens in Treatment Plans?
View More
AAGL Stump the Professors Score: Experts 1, Presenters 2
November 21st 2014A panel of experts were bested only once at the “Stump the Professors” session at the 43rd AAGL Global Congress on Minimally Invasive Gynecology in Vancouver. A sarcoma was the diagnosis that got away among three complex cases presented to a packed audience.
Read More
Could bisphosphonates reduce risk of bone metastasis in breast cancer?
October 16th 2014According to a recent study, low-dose oral bisphosphonates administered to prevent or treat postmenopausal osteoporosis may be associated with a lower risk of skeletal metastasis in patients with early- or more advanced-stage breast cancer.
Read More
Medicaid reimbursement impacts Pap, mammography screening
September 4th 2014An analysis of data from 46 states and the District of Columbia shows that the level of Medicaid reimbursement for office visits has an impact on likelihood of patient screening with Pap tests and other diagnostics for cancer.
Read More
ASCO Guidelines urges discussion of breast cancer risk reduction (VIDEO)
September 4th 2014William Fredette, MD, discusses an updated practice guideline from the American Society of Clinical Oncology (published in the Journal of Clinical Oncology), where it calls on doctors caring for women at increased risk of breast cancer to discuss with them the risks and benefits of specific chemoprevention agents to lower their risk. Video provided by The Doctor's Channel and Reuters.
Read More
New gene linked to breast cancer risk
August 14th 2014Mutations in the PALB2 gene may be associated with a significant increase in the risk of breast cancer, according to a recent study in The New England Journal of Medicine. PALB2 binds to BRCA2-a gene that confers increased lifetime risk of developing breast or ovarian cancer-and likely permits its stable nuclear localization and accumulation.
Read More
Cutting carbs may reduce IGF1 breast cancer recurrence
July 1st 2014A reduced-carbohydrate diet may reduce breast cancer recurrence in women whose tumor tissue is positive for insulin-like growth factor-I (IGF1) receptor, according to a new study in Cancer Epidemiology Biomarkers & Prevention.
Read More
Red meat intake in early adulthood may be linked to breast cancer risk
June 26th 2014Substituting one serving per day of legumes for one serving per day of red meat may help lower a woman’s risk of breast cancer, according to results of a multicenter study based on data from the Nurses’ Health Study II. The findings, published in BMJ, represent 20 years of follow up on a questionnaire on diet.
Read More